Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
Fondazione del Piemonte per l'Oncologia
HiFiBiO Therapeutics
University of Texas Southwestern Medical Center
BioNTech SE
N.N. Petrov National Medical Research Center of Oncology
Slovak Academy of Sciences
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
UNICANCER
Indiana University
Indiana University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vanderbilt-Ingram Cancer Center
Royal Marsden NHS Foundation Trust
The Netherlands Cancer Institute
Wake Forest University Health Sciences
Centre Leon Berard
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
City of Hope Medical Center
Rutgers, The State University of New Jersey
Dana-Farber Cancer Institute
UNICANCER
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Northwestern University
Memorial Sloan Kettering Cancer Center
Vanderbilt University
Indiana University
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute